Tepha

Lexington, United States Founded: 1998 • Age: 28 yrs Acquired By Becton Dickinson
Absorbable biomaterials for medical sutures and meshes are developed.

About Tepha

Tepha is a Healthcare company based in Lexington (United States) founded in 1998, and was acquired by Becton Dickinson in July 2021. Absorbable biomaterials for medical sutures and meshes are developed. Tepha has raised $36.31 million across 9 funding rounds from investors including BD, GE Capital and Westfield Capital. The company has 51 employees. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Diversified. Its legal entity is Tepha Inc. Its competitors include RevBio, Dimension Inx and Ceterix; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 1998 and headquartered in Lexington, United States, Tepha operates in the biomaterials sector. Absorbable medical devices based on polyhydroxyalkanoates (PHAs) are developed and commercialized by the company. Products such as surgical sutures, meshes, films, and composite meshes are offered. 510(k) clearances have been obtained for absorbable monofilament sutures, surgical meshes, and tissue separation films. Superior flexibility, elasticity, biocompatibility, and tensile strength are provided by these materials.

  • Headquarters Lexington, United States
  • Employees 51
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website tepha.com
  • Acquired by Becton Dickinson (Jul 2021)
  • Legal Name Tepha Inc.
Key Metrics
  • Total Equity Funding
    $36.31M (USD)

    in 9 rounds

  • Latest Funding Round
    $11.35M (USD), Series C

    Mar 2012

  • Investors
    BD

    & 5 more

  • Employee Count
    51
  • Acquired by

Funding Insights of Tepha

Tepha has successfully raised a total of $36.31M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $11.35 million completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $36.31M
  • Total Rounds 9
  • Last Round Series C β€” $11.35M
  • First Round $4.43M

    (Mar 2003)

  • Investors Count 5

All 9 funding rounds of Tepha with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2012$11.35MSeries C––
–
May 2011$4.97MSeries C––
–
Jul 2010$3.2MDebt – Conventional––
Feb 2010$2.97MSeries B––
–
Jun 2007$10.7MSeries B––
Mar 2006$3.4MDebt – Convertible––
–
Aug 2004$1.9MSeries A––
–
Dec 2003$810,159Debt – Conventional––
–
Mar 2003$4.43MSeries A––
–
Valuation history

6 investors in total: 6 institutional.

Investors in Tepha

Tepha has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include BD, GE Capital and Westfield Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made in innovative life science companies globally.
nvfund.comBasel, Switzerland
Investments in early and late-stage US companies are made.
vertical-group.comBasking Ridge, United States
Commercial aircraft and equipment leasing and lending services are provided.
1932gecapital.comUnited States
Diversified investment management services are provided by Westfield Capital.
1989westfieldcapital.comBoston, United States
integra-ventures.com
BD is recognized for providing innovative medical technology solutions.
1897bd.comFranklin Lakes, United States
Premium access

Investor details for Tepha

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Tepha

4 dated milestones of Tepha across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Tepha is founded.
  2. Funding First funding round of $4.4M.
  3. Funding Latest funding round, Series C, of $11.3M.
  4. Exit Acquired by Becton Dickinson.

Competitors of Tepha

Tepha has 3 listed competitors in our database, 3 of them funded. They include RevBio, Dimension Inx and Ceterix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
revbio.com2014Lowell, United States$24.42M
Synthetic adhesives for bone and dental repair are developed.
dimensioninx.com2017Chicago, United States$15.42M
3D biomaterials are provided for regenerative medicine applications.
ceterix.com2010Menlo Park, United States$73.88M63
Novel suture passers for arthroscopic orthopedic surgery are developed.
Premium access

Detailed competitors of Tepha

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Medical Equipment & Supplies

3 companies that operate in the same segment as Tepha (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Robotic waterjet system for prostate tissue removal is developed.
2009Redwood City, California, United StatesUSD 348.84 MUSD 308.05 M756
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Injectable packaging, containment, and delivery solutions are manufactured.
1923Exton, Pennsylvania, United StatesUSD 8.15 B6,357
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Tepha

Premium access

Complete news archive for Tepha

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tepha

Tepha was founded in 1998 and raised its 1st funding round 5 years after it was founded.

Tepha is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Tepha is a funded company, having raised a total of $36.31M across 9 funding rounds to date. The company's 1st funding round was a Series A of $4.43M, raised on Mar 2003.

Tepha has 51 employees.

Founded in 1998 and headquartered in Lexington, United States, Tepha operates in the biomaterials sector. Absorbable medical devices based on polyhydroxyalkanoates (PHAs) are developed and commercialized by the company. Products such as surgical sutures, meshes, films, and composite meshes are offered. 510(k) clearances have been obtained for absorbable monofilament sutures, surgical meshes, and tissue separation films. Superior flexibility, elasticity, biocompatibility, and tensile strength are provided by these materials.

Tepha's top competitors include RevBio, Ceterix and Dimension Inx.

Tepha has 6 investors. Key investors include BD, GE Capital, Westfield Capital, Integra Ventures, and Novartis Venture Fund.

Tepha operates through Tepha Inc..

Yes. Tepha was acquired by Becton Dickinson in July 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available